Home > Compound List > Product Information
Butabarbital_Molecular_structure_CAS_125-40-6)
Click picture or here to close

Butabarbital

Catalog No. DB00237 Name DrugBank
CAS Number 125-40-6 Website http://www.ualberta.ca/
M. F. C10H16N2O3 Telephone (780) 492-3111
M. W. 212.24564 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 122

SYNONYMS

IUPAC name
5-(butan-2-yl)-5-ethyl-1,3-diazinane-2,4,6-trione
IUPAC Traditional name
butabarbital
Brand Name
Unicelles
Butatab
Butabarb
Butalan
Butatal
Buticaps
Butisol Sodium
Medarsed
Nilox
Butisol
Sarisol
Sarisol No. 1
Synonyms
Butrate
Sodium Butabarbital
Secbutabarbital
Butabarbital Sodium
Butabarbitone
Secbubarbital
Secbutobarbitone
Secbutobarbital

DATABASE IDS

CAS Number 125-40-6
PubChem CID 2479
PubChem SID 46505051

PROPERTIES

Hydrophobicity(logP) 1.5
Solubility 1360 mg/L

DETAILS

Description (English)
Item Information
Drug Groups illicit; approved
Description Butabarbital (trade name Butisol) is a prescription barbiturate sleep aid. Butabarbital has a particularly fast onset of effects and short duration of action compared to other barbiturates, which makes it useful for certain applications such as treating severe insomnia and relieving anxiety before surgical procedures; however it is also relatively dangerous particularly when combined with alcohol, and so is now rarely used, although it is still prescribed in some Eastern European and South American countries. Its short duration of action gives butabarbital a high abuse potential, comparable to secobarbital. [Wikipedia]
Indication For short-term treatment of insomnia and anxiety disorders
Pharmacology Butabarbital, a barbiturate, is used for the treatment of short term insomnia. It belongs to a group of medicines called central nervous system (CNS) depressants that induce drowsiness and relieve tension or nervousness. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.
Toxicity Signs of overdose include confusion (severe), decrease in or loss of reflexes, drowsiness (severe), fever, irritability (continuing), low body temperature, poor judgment, shortness of breath or slow or troubled breathing, slow heartbeat, slurred speech, staggering, trouble in sleeping, unusual movements of the eyes, weakness (severe).
Affected Organisms
Humans and other mammals
Elimination Barbiturates are metabolized primarily by the hepatic microsomal enzyme system, and most metabolic products are excreted in the urine.
External Links
Wikipedia
Drugs.com

REFERENCES